Department of Virology II, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
PLoS Pathog. 2024 Feb 15;20(2):e1012022. doi: 10.1371/journal.ppat.1012022. eCollection 2024 Feb.
Enterovirus A71 (EV-A71) infection involves a variety of receptors. Among them, two transmembrane protein receptors have been investigated in detail and shown to be critical for infection: P-selectin glycoprotein ligand-1 (PSGL-1) in lymphocytes (Jurkat cells), and scavenger receptor class B member 2 (SCARB2) in rhabdomyosarcoma (RD) cells. PSGL-1 and SCARB2 have been reported to be expressed on the surface of Jurkat and RD cells, respectively. In the work reported here, we investigated the roles of PSGL-1 and SCARB2 in the process of EV-A71 entry. We first examined the expression of SCARB2 in Jurkat cells, and detected it within the cytoplasm, but not on the cell surface. Further, using PSGL-1 and SCARB2 knockout cells, we found that although both PSGL-1 and SCARB2 are essential for virus infection of Jurkat cells, virus attachment to these cells requires only PSGL-1. These results led us to evaluate the cell surface expression and the roles of SCARB2 in other EV-A71-susceptible cell lines. Surprisingly, in contrast to the results of previous studies, we found that SCARB2 is absent from the surface of RD cells and other susceptible cell lines we examined, and that although SCARB2 is essential for infection of these cells, it is dispensable for virus attachment. These results indicate that a receptor other than SCARB2 is responsible for virus attachment to the cell and probably for internalization of virions, not only in Jurkat cells but also in RD cells and other EV-A71-susceptible cells. SCARB2 is highly concentrated in lysosomes and late endosomes, where it is likely to trigger acid-dependent uncoating of virions, the critical final step of the entry process. Our results suggest that the essential interactions between EV-A71 and SCARB2 occur, not at the cell surface, but within the cell.
肠道病毒 A71(EV-A71)感染涉及多种受体。其中,两种跨膜蛋白受体已被详细研究,并被证明对感染至关重要:淋巴细胞中的 P 选择素糖蛋白配体-1(PSGL-1)(Jurkat 细胞)和横纹肌肉瘤(RD)细胞中的清道夫受体 B 类成员 2(SCARB2)。据报道,PSGL-1 和 SCARB2 分别在 Jurkat 和 RD 细胞表面表达。在本报告的工作中,我们研究了 PSGL-1 和 SCARB2 在 EV-A71 进入过程中的作用。我们首先检查了 Jurkat 细胞中 SCARB2 的表达情况,发现它位于细胞质内,而不在细胞表面。此外,使用 PSGL-1 和 SCARB2 敲除细胞,我们发现尽管 PSGL-1 和 SCARB2 对于病毒感染 Jurkat 细胞都是必不可少的,但病毒附着到这些细胞仅需要 PSGL-1。这些结果促使我们评估 SCARB2 在其他 EV-A71 易感细胞系中的细胞表面表达和作用。令人惊讶的是,与之前的研究结果相反,我们发现 SCARB2 不存在于 RD 细胞和我们检查的其他易感细胞系的表面,尽管 SCARB2 对于这些细胞的感染是必不可少的,但它对于病毒附着是可有可无的。这些结果表明,除了 SCARB2 之外,还有其他受体负责病毒与细胞的附着,并且可能负责病毒粒子的内化,不仅在 Jurkat 细胞中,而且在 RD 细胞和其他 EV-A71 易感细胞中也是如此。SCARB2 高度集中在溶酶体和晚期内体中,在那里它可能引发病毒粒子的酸依赖性脱壳,这是进入过程的关键最后一步。我们的结果表明,EV-A71 与 SCARB2 之间的必需相互作用不是在细胞表面发生,而是在细胞内发生。